Your provider will be able to monitor your weight loss and determine if you are a candidate for GLP-1s, and whether microdosing could be effective for you
J Trace elements Electrolytes Health Dis (1994) 8(3-4):15965
Parkes, D., Jodka, C., Smith, P., Nayak, S., Rinehart, L., Gingerich, R., Chen, K., Young, A
J Neuroinflammation 15(1):337 Kim DS, Choi HI, Wang Y, Luo Y, Hoffer BJ, Greig NH (2017) A new treatment strategy for Parkinsons disease through the gutbrain axis: the glucagon-like peptide-1 receptor pathway
While generally considered safe for most individuals, the evidence supporting their use specifically for GLP-1-related digestive symptoms remains limited and largely anecdotal